2009
DOI: 10.1016/j.regpep.2008.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the effects of peripherally administered kisspeptins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
48
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 67 publications
(52 citation statements)
references
References 38 publications
3
48
0
1
Order By: Relevance
“…Accordingly, KP release into the monkey median eminence was found to be pulsatile, with secretory peaks that coincide with the LH pulses [64]. Furthermore, the proposed axonal site of action for KP is in accordance with the observation that the peripheral injection of KP results in rapid increases of LH release [23,35,36,65] which can be prevented with the GnRH antagonist acylin [65]. KP is likely to influence GnRH neurons outside the blood-brain barrier because it does not induce c-fos expression in GnRH cell nuclei of the preoptic area.…”
Section: Discussionmentioning
confidence: 74%
“…Accordingly, KP release into the monkey median eminence was found to be pulsatile, with secretory peaks that coincide with the LH pulses [64]. Furthermore, the proposed axonal site of action for KP is in accordance with the observation that the peripheral injection of KP results in rapid increases of LH release [23,35,36,65] which can be prevented with the GnRH antagonist acylin [65]. KP is likely to influence GnRH neurons outside the blood-brain barrier because it does not induce c-fos expression in GnRH cell nuclei of the preoptic area.…”
Section: Discussionmentioning
confidence: 74%
“…Interestingly, kisspeptin levels showed a strong positive correlation with FAI in obese patients with PCOS. The effect of kisspeptin on free testosterone levels has been previously documented in adult mice, and peripheral administration of kisspeptin analogues was found to strongly increase serum testosterone levels when given systemically [27]. Also, a recent study by Brown et al [28] showed that in the hypothalamus of dihydrotestosterone-treated rodents, kiss1 mRNA and levels of kisspeptin immunoreactivity were significantly reduced.…”
Section: Discussionmentioning
confidence: 98%
“…Shorter isoforms of kisspeptin, consisting of the 10-, 13-, and 14-amino acid amidated C-terminal sequences, also possess biological activity and have been shown to have potency similar to that of the longer form in vitro (Mead et al, 2007b;Mikkelsen et al, 2009), although a discrepant report exists (Pheng et al, 2009). The shorter isoforms have been reported to have a lower potency in vivo than KP-54 (Thompson et al, 2009), possibly as a result of increased susceptibility to degradation in the circulation.…”
Section: A Naturally Occurring Agonistsmentioning
confidence: 99%